About Megan Dow
Form D filings for Belenos Biosciences in 2024 list Megan Dow as executive officer.
Megan Dow first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Megan Dow in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Megan Dow works with at each company, as listed on that company's latest Form D.
Belenos Biosciences, Inc. · Form D, Jul 17, 2024
BC
Bo Chen
Director
CG
Carl Gordon
Director
TD
Tania Dimitrova
Executive officer
DW
David Wang
Director
SM
StJohn McGrath
CEO and President, director